2026 POSTER PRESENTATIONS
Preliminary List as of April 17, 2026
2bind
Binding Kinetics Measured on Cells – Pain or Gain?
2bind
The Format Matters: Stabilities of Bispecifics
A-Alpha Bio
Beyond the PDB: The Synthetic Epitope Atlas for Training Antibody Design Models
A-Alpha Bio
Multi-Objective Engineering of Dual-Specific Antibodies Using AlphaBind
A-Alpha Bio
The Synthetic Epitope Atlas (SEPIA): Large-Scale Validation of De Novo Designed Epitopes to Accelerate Antibody Engineering
AAX Biotech AB
Opti-mAb®: A Novel scFv Format for Improved Therapies
Abalone Bio
Metabolic Class B GPCR Agonist Antibodies Discovered by Library-Scale Functional Selection
Abalone Bio
Targeting Inflammation and Fibrosis with CB2 Agonist Antibodies: Preclinical Efficacy in MASH and Neuropathy Models
AbbVie, Inc.
Automated Immunopeptidomics: High-Throughput MHC Peptide Profiling on the AssayMap Bravo Platform
Absci Corp
ORIGIN-1: An Experimentally Validated Generative AI Platform for De Novo Antibody Design Against Zero-Prior Epitopes
Abterra Biosciences, Inc.
GRIFFIN: A Mass Spectrometry-Based Method for Polyclonal Antibody Sequencing Directly from Protein
Abterra Biosciences, Inc.
VHH Discovery Beyond B Cells - Antibody Discovery from Serum Using Machine Learning Models for In Silico Selection
AbTherx
Leveraging Fully Human Long CDRH3 and Common Light Chain Transgenic Technologies for GPCRs and Complex Modalities
AbTherx
Utilizing Fully Human Long CDR3 Transgenic Mice for Antibody Discovery Against Recessed Epitopes and Challenging Targets
Academia Sinica
Multiomic Profiling of CAR-T Cells Identifies Drivers of Long-Term Persistence
Adimab
Specificity of Rare High-Affinity Human TCRs Derived from Synthetic Yeast-Based Libraries
Adimab LLC
AI-Ready by Design: Data Integration Improves Adimab's Antibody Discovery and Engineering Platform
Adimab LLC
Anti-CD3 Heavy Chain-Only Antibody (HCAb) Panel for Use in T-Cell Engaging Therapeutics
Adimab LLC
Harnessing the Adimab Platform for the Discovery of TTX-080: A Clinical HLA-G Antibody
Agilent Technologies
Accurate mAb Sizing by CE-SDS Using the NIST mAb as a Ladder for the Agilent ProteoAnalyzer System
AI Proteins
PURExpress® Enables High Throughput, Cell-Free Synthesis of De Novo Miniprotein Binders and SPR Dissociation Rate Ranking
Ajinomoto Co., Inc.
Corynex® for Next-Generation VHHs: Site-Specific Conjugation via ncAA Incorporation and Half-Life Extension via PASylation®
Ajinomoto Co., Inc.
Corynex®: Scalable Secretion Service for Long-Chain Peptides Including GLP-1-Related Peptides
Albert Einstein College of Medicine
Accurate Affinity Models for SH2 Domains from Peptide Binding Assays, Free-Energy Regression and Importance of Library Structure
Albert Einstein College of Medicine
Bioconjugation Approaches for Personalized Endogenous T Cell Therapies
Albert Einstein College of Medicine
Development of Innate Immune Cell Redirectors for the Depletion of Antigen Specific Autoreactive T Cells
Albert Einstein College of Medicine
Development of Major Histocompatibility Complex Class II Scaffolds for the Selective Modulation of Antigen-Specific CD4 T Cells
Albert Einstein College of Medicine
Influenza B Virus Bispecific Antibodies that Simultaneously Target Hemagglutinin and Neuraminidase
Alloy Therapeutics
Accelerating Single-Domain Antibody Discovery and Optimization via Mammalian Cell–Based Directed Evolution and AI/ML-Guide Digital Design
Altruist Biologics Suzhou Co., Ltd.
Addressing Challenges of Complex Molecules with a CMC Strategy Framework
Ankyra Therapeutics
Anchored Fully Humanized Monoclonal Antibodies for Cancer Treatment
Antibody Solutions
Unlocking the Full Potential of Rabbit Monoclonal Antibodies with Cellestive™
Antiverse
AI-Guided Design of Functional Antibodies with Tailored Properties Against Challenging Targets
Apoha
Mapping Formulation-Dependent Protein Behavior with the Liquid Brain
Apoha
What Does the Liquid Brain See? From Coalescence Physics to Molecular Structure
Aragen Life Sciences
Comprehensive Discovery Biology Solutions in Cell and Protein Sciences for Accelerating Your Drug Discovery Programs
Ardigen S.A.
AI-Driven De Novo Generation of Protein Binders
Ardigen S.A.
ARDiTox: Safer pHLA-Targeted Immunotherapies Through AI and Computational Immunology
argenx BVBA
Immunology Innovation Program: Developing Antibodies Against Novel Targets via Co-Creation
Asimov, Inc.
A Rapid, SPE-free N-Glycan Profiling Workflow for High-Throughput Analysis of Complex Biologics
AstraZeneca
From Months to Weeks: Optofluidic Platform Powers Rapid Antibody Identification Across Indications
AstraZeneca
Identification of Logic Gated ADCs Using Combinatorial Screening
AstraZeneca
Modular Generation of Multispecific Antibodies Using Protein Trans-Splicing
AstraZeneca
Single Domain Antibodies with Broad and Potent Activity Against Seasonal and Non-Seasonal Influenza A Viruses
ATUM
A Novel Bispecific Approach to Eliminate Light Chain Mispairing
ATUM
A Seamless In Silico-to-Expression Pipeline: Ultra-Rapid Antibody Generation and Analytics
ATUM
Utilizing Transposases for Expression of Complex Modalities and Precision Genome Engineering
Aureka Biotechnologies
ActRIIA/ActRIIB Dual Antagonist mAb Drives Weight Loss While Preserving Lean Muscle
Aureka Biotechnologies
Closed-Loop High-Throughput Biology and AI for Functional Antibody Discovery
AVS Bio
Advancing VHH Discovery Leveraging a High Throughput B Cell-Based Platform to Maximize Diversity and Target Specificity
Binghamton University, State University of New York
Linker Engineering of FGFR4-Targeted Exatecan Antibody–Drug Conjugates Enables Potent Antigen-Dependent Cytotoxicity and Improved Pharmacokinetic Performance
Binghamton University, State University of New York
Next-Generation Immunosuppressive ADCs: Targeted Delivery of Glucocorticoids to Activated Immune Cells for Chronic Inflammation
Biocytogen Pharmaceuticals
BCG015: A First-in-Class Antibody-Drug Conjugate Targeting TM4SF5 for the Treatment of Hepatocellular Carcinoma
Biocytogen Pharmaceuticals
CRB2104: A 2:1 AMHR2/CD3 T Cell Engager Targeting AMHR2-Positive Solid Tumors
Biocytogen Pharmaceuticals
Novel Blood-Brain Barrier Penetrating Heavy Chain-Only Antibodies Targeting CD98
BioDlink
GL-DisacLink® - A Promising Technology for Glycosite-Specific Conjugation
Biointron
AbDrop™ Speeds: Accelerating Your Antibody Discovery with Single B Solution
Biointron
Data-Driven Developability Assessment of Antibody Candidates Using High-Throughput Biophysical Assays
Biointron
Speed Counts While Quality Matters: A Fast-Track Approach to Bispecific Antibody Production
Bionova Scientific
Peptide Mapping, Perfected: In-House LC-MS from NIST Standards to Complex Biotherapeutics
Bio-Rad Laboratories, Inc.
Payload Specific Antibody Discovery for ADCs from HuCAL® Phage Display Antibody Library
Bio-Rad Laboratories, Inc.
Pioneer Platform: A Novel Biotherapeutic Antibody Discovery Platform
Bio-Rad Laboratories, Inc.
Rapid Generation of Bispecific Antibodies for High Throughput Screening with SpyLock Technology
Biotage
High-Throughput, Automated Large-Scale Plasmid Purification: Eliminating Manual Bottlenecks in the Therapeutic Pipeline
Bio-Techne
High-Throughput Antibody Production Coupled with Rapid Charge and Size Characterization by icIEF and CE-SDS
Bio-Techne
Streamlined Cell Line Development of a CD28 Antibody: Integrating TcBuster™ and Ambr® Technology with Multi-Attribute Characterization
Boehringer Ingelheim Pharmaceuticals, Inc.
Challenges and Opportunities in Targeting Peptide-HLAs with Antibody Therapeutics for Oncology
Boehringer Ingelheim Pharmaceuticals, Inc.
Discovery to Development: Computational Approaches for Immunogenicity De-Risking
Boehringer Ingelheim Pharmaceuticals, Inc.
Engineering Towards the Utopia Point: Multi Objective Design of Biocatalyst Proteins
Boehringer Ingelheim Pharmaceuticals, Inc.
FcRn Recycling Assay for Characterizing Antibody-Based Therapeutics
BOKU - University of Natural Resources and Life Sciences
Engineering a Small Molecule–Controlled Switch for CAR T Cell Regulation
BOKU - University of Natural Resources and Life Sciences
Engineering CAR T Cells to Specifically Target Ligand-Activated EGFR
BOKU - University of Natural Resources and Life Sciences
miniCARbids - A Novel Engineering Platform for Small, Human-Derived Binding Domains Tailored for Car T Cell Therapy
BPS Bioscience, Inc.
Advanced Tools for Bispecific Antibody Generation and Validation
Broad Institute of MIT and Harvard
Evolution of Botulinum Neurotoxin Proteases To Induce Inflammatory Cell Death in Cancer Cells
Broad Institute of MIT and Harvard
RABIT: Rapid Automated Binder Identification Technology
Broad Institute of MIT and Harvard
SpySPR: Rapid High-Throughput SPR Characterization for Nanobody Discovery Using Unpurified VHH from IVTT Reaction
brown univ
Developing a Size-Based Microfluidic Electrophoresis Method to Determine the Drug-to-Antibody Ratio of Antibody-Drug Conjugates
Bruker Biosensors
Integrated Biophysical Analysis of Fc–FcR Binding, Affinity, and Avidity in Antibody Therapeutics
Bruker Cellular Analysis
Function-First Single-Cell Discovery and Characterization of Bispecific T Cell Engagers
Carterra, Inc.
Characterizing Challenging Membrane Targets Using HT-SPR
Carterra, Inc.
Strategies for Scalable and Sensitive Determination of High Affinity and Slow Dissociating Binding Interaction Kinetics in Antibody Discovery
Cell Microsystems
Automated Antibody Discovery and Screening Using CellRaft® Technology
Cellplus Biotechnology (Suzhou) Ltd.
High-Titer (>1.8 g/L) and Cost-Efficient Transient Expression in CHO-K1 Cells: Enabled by an Optimized Plug-and-Play System and PEl-Based Approach
Charles River Laboratories
New Approach Methodologies (NAMs): Retrogenix® Technology for Rapid Early-Stage High-Throughput Screening and Toxicology Species Selection
Charles River Laboratories
Synergy that Strengthens Safety: The Combined Application of Tissue Cross-Reactivity (TCR) and the Retrogenix® Cell Microarray Platform for More Comprehensive Safety Assessment
Chemical Computing Group
3dpredict/Ab - High Throughput Antibody Structure and Ensemble Protein Property Predictions
Chemical Computing Group
Pharmacophore-Guided Virtual Screening of Antibody Formats
ChemPartner
Integrated Biologics Discovery Platform: Accelerating Complex Modality Development Through AI-Augmented Engineering and Comprehensive Characterization
Chinese University of Hong Kong
Prediction of Immunogenicity and Vaccine Effectiveness Using Viral Genomic Variation
Coding Bio
A Function-First ML-Guided High Throughput Screening Platform for the Discovery of VHH-Based T-Cell Engagers
Columbia University
Engineering Dendritic Cell-Targeting Nanobodies for Antigen Delivery
Conigen Bioscience
A Panel of Class A, B and F GPCR-Specific Antibodies Can Detect the Targets Expressed on Live Cell Surfaces by Flow Cytometry
Conigen Bioscience
Multi-Pass Complex Proteins Displayed on Virus-Like Particles Are Bioactive in Binding to Specific Antibodies and Ligands
Conigen Bioscience
Novel Soluble Fc-Free CD19 Dimeric Protein for Specific, Sensitive and Broadly Applicable CD19 CAR-T Cell Detection by Flow Cytometry
Cube Biotech GmbH
From Copolymer Screening to Plug-and-Play Purification: Automated NativeMP™ Platforms for Membrane Proteins
Cytiva
Accelerating Biosimilars Development with Biacore™ Sensorgram Comparison
Deeptope
Antibody Optimization Case Studies by Deep Mutational Scanning
Deeptope
Epitope Mapping Case Studies by Deep Mutational Scanning
Development Center for Biotechnology
LYSward™ : An Engineering Platform to Generate a pH-Dependent Antibody for Antibody Drug Conjugate
Diffuse Bio, Inc.
RamaX: A Platform for Ultra-Rapid Binder Screening, Discovery, and Optimization
Dotmatics
Antibody & Therapeutics Discovery: Interrogating large NGS Datasets
Eli Lilly and Company
Engineering Bispecific VHHs as Biased IL-10 Receptor Agonists for Inflammatory Bowel Disease
Eli Lilly and Company
Utilization of Chelators for Analyzing Oxidative Degradation of Antibody Therapeutics
ETH Zurich
Engineering VHH Fusion Antibodies Targeting a Key Driver of Liver Metastasis Formation in Colorectal Cancer
Eurofins DiscoverX
Integrated Evaluation of Payload-, Fc-, and Target-Mediated Mechanisms of ADCs Using Streamlined Complementary Platforms
Eurofins DiscoverX
Mechanism-Driven Cell-based Assays to Screen & Characterize Bi-Specific Antibodies
Eurofins DiscoverX
Unlocking Agonism: A Comprehensive Strategy to Characterize Agonistic Antibodies for Immunotherapy & Autoimmunity
evitria AG
Screen, Select, Enhance: An Integrated Workflow for ADCC-Enhanced Antibody Development
EvolveImmune Therapeutics
Engineering EVOLVE-101: A CD180 Targeting T Cell Engager with Integrated CD2 Co-Stimulation
FairJourney Biologics
Accelerating Drug Discovery: De-Risking Complex Multi-specific and Multi-Format Biologics with a CMC-Predictive Mammalian Display Platform
FairJourney Biologics
Dissecting Human and Cyno FcRn Interactions to Drive Antibody Half-Life Design and Fast Track Development
FairJourney Biologics
Driving Antibody Optimization with Broad-Space and Structure Guided Platforms: Tumbler™ and Targeted Engineering
FairJourney Biologics
EXPLORER Platform: Fast-Track of Potent and Developable Antibodies to IND
Fapon Biopharma
FPE024,a CD19/BCMA Dual-targeting VHH Format T-Cell Engager with Novel CD3 Binder for Enhanced Potency and Safety Profile
FASI Food Allergy Science Initiative Inc
Molecule-Specific Compatibility of Bispecific Scaffolds: The Necessity of Multi-Format Empirical Testing for Novel Fab Pairs
Fidabio
Characterising Multivalent Complex Formation Using Controlled Complex Lifetime with FIDA
Fidabio
Clone Selection from Un-Purified Samples
Fluidic Sciences Ltd.
Detection of Antibody-Secreting Cells in Cyto-Mine® Chroma: Comparison of Two Bead-Based and One FRET Antigen-Specific Assays
Fluidic Sciences Ltd.
Machine Learning Guided Interaction Analysis
Forge Biologics, a member of Ajinomoto Bio-Pharma Services
Expanding the Potential of Antibody Conjugates: AJICAP® Technology for Versatile DAR Control and Novel Modality Applications
Fortis Life Sciences
Cross-Reactivity and Selectivity Comparisons Between Immune-Derived and Discovery Libraries from the AbNano Platform
Fortis Life Sciences & SPOC Biosciences
Rapid and High-Throughput SPR Characterization of VHH Discovery Leads Across Related Polymerase Targets for LAMP Dx
Fusion Antibodies plc
A Rational Affinity Maturation Platform - RAMP
Fusion Antibodies plc
OptiMAL®: Mammalian Display for Antibody Discovery
Gator Bio
AI-Engineered NovoBody™-Based Probe for “High Capacity, Low Drift” BLI Analysis of His-Tagged Proteins
Gator Bio
Streamlining Biologic Workflows with Label-Free Quantitation and Binding Analysis
Gator Bio
The Evolution of Antibody Screening: Automation-Integrated BLI for Next-Generation Discovery Workflows
Genedata AG
A Digital Platform for the Development of Next-Generation Antibody Drug Conjugates (ADCs) and Other Antigen-Targeting Conjugates
Genedata AG
Harmonizing and Streamlining Chromatography and Electrophoresis Data Workflows with Genedata Chromatics
Genedata AG
High Throughput Mass Spectrometry Analytics for ML/AI Ready Drug Discovery
Genentech
A Strategy to Produce a "Self-Destructive" Enzyme by Harnessing Its Activity Profile
Genentech
Establishing Reliable PK Evaluation Criteria: A Validated Transcytosis Assay for Monoclonal Antibodies and Comparative Study with SCID PK
Genentech
Surface-Aware Deep Learning for Prediction of Protein Hydration Thermodynamics from Conformationally Diverse Structures Using GIST Labels
GeneScience Pharmaceutical Co., Ltd.
GenSci155, a Novel Long-Acting IGF-1 Peptide Analog for the Treatment of sPIGFD, BPD and AIS Diseases
GENEWIZ from Azenta Life Sciences
A Novel AI/ML Approach to Codon Optimization for Enhanced Antibody Expression
GENEWIZ from Azenta Life Sciences
Leveraging High-Throughput Platforms for the Discovery of Bispecific Antibodies
GenoBioTX
Development of Fully Human Anti-CD71 Monoclonal Antibodies with Blood-Brain Barrier Penetration Using the SmocMab Platform
Genovac Antibody Discovery LLC
Strategic Use of Advanced Technologies and Multiple Host Species to Rapidly Generate Cost-Effective Antibody Candidates
GenScript
A Next-Generation Transient CHO Expression Platform Accelerating Antibody Discovery from Screening Service to In-House Production
GenScript
Accelerating AI-Driven Discovery with an Integrated Cell-Free Sequence-to-Data Platform
GenScript
Improving Scalable, High-Throughput Affinity Protein Purification Workflows with Magnetic Beads-Based Automated Solutions
Gilead Sciences
Dynamics of Immune Activation and Killing Induced by HBV T Cell Engagers
Gilead Sciences
Leveraging Prior Knowledge: Potency Assay Development for a Multi-Paratopic Biologic
Ginkgo Bioworks
PROPHET-Ab: An Automated Platform for High-Throughput Antibody Production and Developability Characterization
Ginkgo Bioworks
Reagents for High-Yield, Automation-Friendly Protein Expression: Cell Free Protein Synthesis Kits and Engineered Pichia pastoris
GO Therapeutics
Tumor-Restricted Tn- MUC1 Glycoepitopes Enable Precision ADC Therapy with Robust Efficacy and Favorable Safety
GSK
Enhancing Solubility and Expression of a Binder Through Targeted Linker Engineering
H. Lee Moffitt Cancer Center & Research Institute
A Therapeutic Nanobody Targeting ENPP1 Reveals Tumor Control and Engages the Nuclease-Like Domain
Harvard University
Precision Brain Shuttle Platform Tailored to Breast Cancer Brain Metastasis
i3 Membrane Corporation
A001: Digital Membrane Chromatography — A New Way to Rapid Antibody Purification for Top-Down Mass Spectrometry
i3 Membrane Corporation
B001: Electrochemical Elution Reduces Aggregation of pH-Sensitive Monoclonal Antibodies in Digital Membrane Chromatography
ICGEB - International Centre for Genetic Engineering & Biotechnology
Development of Novel Anti-Malarial Antibody Drugs against Plasmodium falciparum
Icosagen Cell Factory OÜ
Early Antibody Developability Package — Reducing Manufacturing & Clinical Risks
Icosagen Cell Factory OÜ
Engineering and Manufacturing of Complex Biologics: AI-Guided Optimization of Multispecific Antibodies
Illimis Therapeutics
Engineering a GAS6 Fusion Protein (GAIA) enabling Non-Inflammatory Amyloid-ß Clearance for Safer Alzheimer’s Disease Therapy
Immatics Biotechnologies GmbH
Comprehensive Profiling of HLA Class II Immunopeptidomes to Discover Targets for Autoimmune Diseases
Immatics Biotechnologies GmbH
Unlocking Tumor Access: Targeting COL6A3 on the Stroma of Solid Tumors with a TCR-Based Bispecific
ImmuneSpec
Extending MAPPs-Based Immunogenicity Risk Assessment to Therapeutic Peptides and Antibody–Drug Conjugates
Immuto Scientific
Multimodal Fusion of Empirical Structural Data and Deep Learning for Improved Modeling of Antibody–Antigen Complexes
Insilico medicine
Enhancing Antibody Developability Prediction with Hybrid Sequence–Structure Modeling
Institute for Protein Innovation
A Non-Profit Institute’s Community Based Approach to Make Highly Validated Recombinant Antibodies for Scientific Research
Institute for Protein Innovation
A Systematic Evaluation of Fusion Tags and Chaperone Proteins To Improve Antigen Solubility and Yield
Institute for Protein Innovation
Discovery of Developable VHHs from a Humanized Synthetic Yeast Display Library
Institute for Protein Innovation
High-Throughput SPR Workflows for Antibody Characterization at IPI: Kinetics and Epitope Binning
Institute for Protein Innovation
IPIAbDev: Interpretable Machine Learning for Antibody Developability Prediction and Discovery
Institute for Protein Innovation
Library vs Library Selection Platform for Discovery of Epitope Specific Antibodies
Integral Molecular
A New Approach Methodology (NAM) for Specificity Testing
Integral Molecular
Antibody Reagents to Validate Impossible Protein Targets
Integral Molecular
CDR-Scanning for Antibody Engineering and New IP
Integrated DNA Technologies
Diverse Library Generation using IDT oPools and Synthetic Biology Custom Solutions
Invenra
Enabling Rapid Bispecific Antibody Discovery with Invenra’s B-Body Platform
Invenra
From High-Quality mAb Discovery to Multispecific Therapeutics: Discovered. Designed. Delivered
IQVIA Laboratories
End to End Protein Science Solutions Enabling Translational Research and Clinical Assays
IQVIA Laboratories
New Approach Methodologies for Risk Assessment and Functional Evaluation of Drug Candidates
Jackson Laboratory
A New and Differentiated Transgenic Platform for Rapid Generation of Developable Human Therapeutic Antibodies
Jackson Laboratory
NSGF6T, a Humanized Mouse Model Recapitulating Key Features of Psoriasis for Translational Research
Jasco, Inc.
Rapid and Robust Evaluation of Higher Order Structural Differences in Bispecific Antibodies by Circular Dichroism Spectroscopy
Johns Hopkins University
Biofloating: A Cell-Based Workflow for the Discovery of Antibodies Targeting Multi-Pass Transmembrane Proteins
Johns Hopkins University
Design of a Suspension-Based Mammalian Cell Interaction Platform for Antibody Discovery
Johns Hopkins University
Engineered CD19-Targeting Interleukin-21 Mimetic to Study and Manipulate B-Cell Biology
Johns Hopkins University
Engineered Multi-Paratopic Antibody-Drug Conjugates Target and Destroy Tumor Cells Through Multiple Modalities
Johns Hopkins University
Engineering a High Affinity SARAH Domain for Hippo Signaling Inhibition
Johns Hopkins University
Engineering a Novel Interleukin-2-Based Immunocytokine with Enhanced Effector and Memory Function
Johns Hopkins University
Engineering Antibody-Invertase Fusion Proteins for Quantitative Detection of Infectious Disease-Specific Antibodies Using Commercial Glucometers
Johns Hopkins University
Engineering Interleukin-4-Based Antibodies Fusion Proteins for Targeted Immune Modulation
Johns Hopkins University
Mechanistic Insights into the Immunomodulatory Effects of a Potentiating Antibody Targeting the Interleukin-7 Cytokine
Johns Hopkins University
Targeted Antibody/Cytokine Fusion Protein Antagonists to Overcome T[reg]-Mediated Immunosuppression in Tumors
KACTUS
Recombinant Kallikrein (KLK) Family Proteins
KACTUS
The Native Edge: KACTUS CD3 VLPs and Nanodiscs for Precision T-Cell Therapy and Discovery
KACTUS
Transforming Tumor Research: Engineering MHCs as Versatile Reagents
Kaneka Eurogentec SA Biologics
GMP VHH Platform for Rapid Tox and Clinical Access
Kimialys
K-Neuro: An SPR-Based Platform for Accelerating Drug Discovery in Neurodegenerative Diseases
Kite Pharma, a Gilead Company
Accelerated Production of Biotinylated Protein Reagents Through Coexpression with Biotin Ligase
Korea Institute of Science and Technology
Programmable DNA Nanostructures for Spatial Organization and Delivery of Growth Factor–Mimicking Peptides
Korea Institute of Science and Technology
Unlocking Therapeutic Potential: Why Site-Specific Hybridization is Essential Over Non-Specific Peptide Adsorption on DNA Origami
Kuhner Shaker, Inc.
Kuhner TOM For Off-Gas Analysis in Shake Flasks
KYinno Biotechnology (Beijing) Co., Ltd.
MPSA-AB5000: A High-throughput Membrane Proteins Screening Array for Therapeutic Biologics Specificity Profiling
Kyoto University
Development of Cis-Binding Biparatopic Antibodies as TNFR2 Antagonists
LenioBio GmbH
From AI Designs to Oncology Leads in Days: Bridging the Lab-in-the-Loop Gap with ALiCE®
Lightcast Discovery Ltd.
Envisia: Advancing Antibody Discovery with Function-Focused Profiling at the Single-Cell Level
lino Biotech AG - A Miltenyi Biotec Company
One Platform, Four Applications: Multiplexed Focal Molography for DEL Hit Validation, PROTAC Linker Design, Plasma Protein Binding, and Fc Receptor Profiling
Live Drop
Accelerating Therapeutic Antibody Discovery with High-Throughput Droplet Microfluidics
Live Drop
From iPSCs to Immune Cells: High-Throughput Production and Single-Cell Functional Analysis with Droplet Microfluidics
LiVeritas Biosciences
From 80 Hours to 2: AI-Powered Curation for Therapeutic Protein Sequence Variant Analysis
Ludger Ltd.
Comprehensive Glycosylation Analysis to Meet Regulatory Requirements: Full N-Glycan Characterisation and Quantitation of Sialic Acids
LUMICKS
Avidion: High-Throughput Cell Binding Avidity Platform for Screening Cell Engagers, Multispecific Antibodies, and Cell Therapies
Matwings Technology
Improving Protein Stability Through Deep Learning Method: The MatwingsVenus™ Platform
MaxCyte
Advancing the Discovery and Development of Biologics and Next-Generation Immunotherapies through Innovative Expression and Screening Techniques
Merck Research Laboratories
Enabling High-Throughput CE-SDS and Peptide Mapping Through Automated Characterization Workflows on the Hamilton STARlet
Metaphore Biotechnologies
ML-Guided Design of GLP-2R Agonist Antibodies with Improved In Vivo Activity Supporting Extended Dosing
Metaphore Biotechnologies
Multi-Specific Molecule Discovery with the Metaphore Knowledge Base
Michigan State University
Beyond the Impact: Antibody Sequences as Predictive Biomarkers for Pediatric Traumatic Brain Injury
MilliporeSigma
Rational Design of Protein A Variants Using AI-Driven In Silico Modeling for Enhanced Affinity Chromatography Performance
Miltenyi Biotec B.V. & Co. KG
A Proteotranscriptomic Approach to Generate Monoclonal Antibodies by LC-MS/MS and Single Cell BCR Sequencing
MNDL Bio
Generic Computational AI Based Engine for Protein Expression Optimization: A Standardized Engineering Framework for Global Biomanufacturing
Molecule Mind
Discovery and Preclinical Development of a PD-1/IL-2v Bispecific Antibody Cytokine Fusion Protein with AI-Powered MoleculeOS(MOS) Technology
NanoTemper Technologies
Optimizing Biologics Developability Assessment: A Multi-Parameter Approach With Thermal and Colloidal Stability Measurements for Improved Candidate Selection
NanoTemper Technologies
Synergistic Effects of Co-Solutes and Heat on the Physical Stability of GLP-1am
National Institutes of Health, National Cancer Institute
Discovery of Camel VHH and Shark VNAR Nanobodies by Phage Display for Developing Cancer Therapeutics
National Institutes of Health, National Cancer Institute
Quest for Mucin-4 Glycopeptide Specific Antibodies as Potential Anti-Cancer Immunotherapies
National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases
Engineering Nanobody-Peptide Conjugates to Dissect GPCR Function in Diabetes and Obesity
New England Biolabs, Inc.
Cold-Active TEV Protease: Engineered for Higher Performance at Low Temperatures
New England Biolabs, Inc.
The Versatility of Cell-Free Protein Expression Systems: Comparative Study Across Conditions and Platforms
Nona Biosciences
De Novo Fully Human VH Antibody Discovery Enabled by Nona Biosciences' Hu-mAtrIx™ AI Platform
Northwestern University
Expanding the high-throughput protein stability toolkit with cDNA display pulse proteolysis
Nuclera
From Sequence to Assay-Ready GPCRs in 48 Hours Using Cell-Free Multiplex Screening
Nuclera
Rapid Rank-Ordering of 96 Trastuzumab Variants Using Cell-Free Recombinant Antibody Screening
Oak Ridge National Laboratory
Engineering Amide Synthetases for Sequenced Oligoamide Synthesis
OmniAb
Empowering the Efficient Discovery of Ultralong CDRH3 Antibodies with High-Throughput xPloration® Workflows
OPM Biosciences, Inc.
Compatibility of the OPM-293 Transient Expression Platform with Expi293F and Expi293 Pro Cells Supports Enhanced Protein Production
Ordaos Bio
Development of a Nanobody Producibility Model Using High-Throughput Cell-Free Expression and Purification
PAIA Biotech GmbH
pH-Dependent FcRn Binding and Release Assay in a Microplate: A New Method for Screening Fc Interactions of mAbs, Bispecifics and Fc Engineered Antibodies
PAIA Biotech GmbH
Systematic Developability Profiling of a Large Panel of Bispecifics Derived From Clinical Stage Antibodies
Partillion Bioscience
A High-Throughput Nanovial Workflow for Functional Validation of Immune Cell–Target Cell Interactions
peaccel
Adaptive Quantum Ansatz for Tetrahedral-Lattice Protein Folding
Pentixapharm AG
Harnessing the Best of Both Worlds: GT-008, a Versatile Tumor-Selective Anti-CD24 Antibody for Radiotheranostic and ADC Strategies
Pharmaron
Comprehensive In Vitro Mechanistic Characterization of Dato-DXd, a Trop2 Directed ADC
Pharmaron
Establishment of a Patient-Derived Organoid-Immune Cell Co-Culture Platform for Evaluating Immuno-Oncology Therapies
Pharmaron
In Vitro Assessment of Potential Hematotoxicity of ADC Drugs
Pharmaron
Multi Attribute Monitoring and Comprehensive Analysis of mAb CQAs Throughout the Manufacturing Process
Pharmaron
Profiling ADC In Vitro Catabolism: A Systemic Approach from Incubation to Identification
Pharmaron
Single-Cell RNA-Seq Reveals Insights into the Effects of Immune Checkpoint Inhibitors
Primrose Bio
Preclinical Development of a VHH-ADC Using the Pfenex Platform
PROAnalytics LLC & atSpiro
Increase Antibody Titers in Flasks with Automated Continuous Feeding
ProBio, a GenScript subsidiary
The Discovery and Development of a Bispecific T Cell Engager Prodrug Targeting ENPP3 for Renal Cell Carcinoma (RCC)
ProBioGen AG
Unlocking Rapid, Scalable Lentiviral Vector Production with Stable Pools
ProImmune
Ankyrons® - Next Generation Target Binding and Detection
Prolific Machines
Overcoming Limitations of Constitutive Protein Expression with the Power of Optogenetics
Promega Corporation
Binding to Bridging: Complete Suite of FcγR Assay Tools Accelerates Antibody Therapeutic Development
Promega Corporation
Bioluminescent Assays for Antibody-Drug Conjugate Development: Internalization and Bystander Killing Functions
Promega Corporation
New Methods for MOA-Based Potency Testing and CAR-T Cell Characterization
Protein Metrics by Dotmatics
Automated, High-Throughput Screening of Complex Biologics
Proteintech Germany GmbH
FlexAble 2.0 – A Versatile Tool to Label Antibodies with Dyes, Enzymes or Oligos
Proteintech Germany GmbH
VHHs as Tools for the Analysis of Antibodies and Cytokines Using BLI and SPR
ProtiFi
MAM-Easy: A Standardized Kit-Based Workflow for Reproducible Biotherapeutic Quality Monitoring
Quantum-Si, Inc.
Single-Molecule Protein Sequencing for the Characterization of Proteins, Purification Impurities, and Binding Kinetics
Rapid Novor
Conversion of Polyclonal Anti-Idiotypes into Characterized Recombinant Antibodies
Refeyn, Inc.
Combining icIEF-Fractionation and Mass Photometry to Provide Insights on Bispecific Antibody and Biosimilar Development
Regeneron Pharmaceuticals
Identification of Neoantigen Drug Targets Induced by Tryptophan Depletion
Rondo Therapeutics
Developability of RNDO-564: A Novel CD28 x Nectin-4 Costimulatory bsAb for the Treatment of Solid Tumors
RoukenBio
Development of a high-throughput multimodal patient-derived platform integrating autologous fibroblasts and tumour-infiltrating lymphocytes for colorectal cancer drug discovery
RoukenBio
LocIn: A Targeted Integration System for the Efficient Creation of Isogenic Mammalian Cell Lines
RoukenBio
Target Density Matters - Binding Kinetics of Antibody-Based Therapeutics Are Highly Influenced by Target Expression Levels
Royal Veterinary College
Cell Line Genome Engineering
Sanofi
Towards Nanobody® Thermostability Prediction with In House Sanofi Data
Sanofi
Two Cell Lines, One Goal: Enabling Reliable Cell-Based Assay Critical Reagent Production
Sartorius
From DNA Template to BLI Kinetics in a Day - Using Octet® VHH Biosensors to Directly Analyze VHHs Produced in NEBExpress® and PURExpress® Cell-Free Protein Synthesis Systems
Sartorius
How Low Can You Go? High-Sensitivity Kinetics at Low Concentrations with Biolayer Interferometry
Sartorius
Streamlining Drug Discovery with High-Throughput Screening by Cytometry
Scholar Rock
Design and Evaluation of a Dual Mechanism GLP-1R Agonist- Antibody Fusion for Weight Loss with Lean Mass Preservation
Scripps Research Institute
Structural Insights into In Vivo Antibody Diversification: How CR3022 Evolves to Target Conserved Epitopes for Pan-Sarbecovirus Neutralization
Seismic Therapeutic
Discovery of a Novel IgM Cleaving Protease to Treat Autoimmune Diseases
Seismic Therapeutic
Identification and Characterization of an IgE Eliminating Protease Using Multi-Parameter Molecular Assessment
Seismic Therapeutic
Yeast Display for Protease Engineering and Activity Screening
Selvita S.A.
Early Developability Assessment (EDA) as a Data Driven Precursor for Robust AI/ML Model Training Pipelines
Selvita S.A.
End-to-End Solutions for Protein Biologics: From Target Selection to Drug Delivery
Seoul National University
Advances and Challenges in CAR-T Therapy for Glioblastoma
Seoul National University
Engineered B7-H6 Enhances NKp30-Mediated NK Cell Activation in Bispecific Engagers
Seoul National University
Engineering IL-21 Secretion in T Cells Using Druggable Ligand-Responsive Stabilized Domains
Seoul National University
Precision Fc Engineering via Glycosylation-Competent CHO Display Enables Selective Fc?RIIIa Targeting and Enhanced Antitumor Activity
Seoul National University
Stealth-Body: A Next-Generation IgG Fc Variant with Complete Effector Silencing and Preserved Developability
SeromYx Systems, Inc.
Impact of Fc Engineering on CAR-T Directing mAbs: Derisking Antigen-Specific FcR Binding and Consequent Effector Function
Shanghai Hongcheng Pharmaceutical Co. Ltd.
Discovery and Characterization of a Human and NHP Cross-Reactive Anti-CD3 Nanobody
Slingshot Biosciences
Cell Mimics Provide Robust Control for T Cell Memory Phenotyping Panels
Stanford University
Antibody-Guided Cardiac Surgery: Affinity Maturation and Format Optimization of Dye-Conjugated Anti-Contactin-2
Stevens Institute of Technology
Decoding Local Interactions of Novel Excipients with Antibodies for Viscosity Prediction in High-Concentration mAb Formulations via Molecular Dynamics
Sygnature Discovery
A Structural Platform for Molecular Glues and Protacs Discovery: SPR Fragment Screening and Crystallography Hit Validation With CRBN[midi]
Synaffix BV
Application of Clinical Stage GlycoConnect® Technology to Bispecific Antibodies Yields Improved Bispecific ADCs in Comparison to Randomly Conjugated bsADCs
Synaffix BV
GlycoConnect® ADC toolbox expansion with dual payload ADC (dpADC) technology
Taiho Pharmaceutical Co., Ltd.
Design of Bispecific Antibody Fc Region Employing a Shark-Human Chimeric and Asymmetric Format
Takeda Pharmaceuticals
Light Chain Charge Mutations and Bulk Pool Scouting allow Selection of Minipools expressing 1:1 Bispecifics with Exceptional Product Quality
Takeda Pharmaceuticals
Optimizing Antibody Affinity and Biophysical Properties Using Yeast Display
Takeda Pharmaceuticals
Optimizing Plasmid Construct Workflow and Design for Yield and Cloning Efficiency
Takeda Pharmaceuticals
Pooled Binder Screening for Accelerated CAR gdT Discovery
tecan
Scalable, Automated Monoclonal Antibody Purification: High-Recovery Workflows via AffinEx™ Protein A SPE Cartridges on Resolvex® Positive Pressure Systems
Telix Targeting Technologies
Rational Design of Antibody Fragments with Lower Off-Target Uptake and Retention at Clearance Organs
TenSixty Bio
Discovery of Epitope-Defined Oncology Targets to Enable High Therapeutic Index ADCs
Texas Tech University Health Sciences Center
Optimization of Membrane Scaffold Proteins (MSPs) for Lipid Nanodiscs Reconstitution Using a PD-10 to Improve Quality and Yield for Biophysical Techniques
The Broad Institute
Automation of Ribosome Display for High Throughput Binder Selection
Thermo Fisher Scientific
A Next-Generation Expi293™ PRO Expression System for Enhanced Protein Expression Yields Across Diverse Protein Classes
Thermo Fisher Scientific
Accelerating Discovery and Rational Engineering of Antibody Modalities Using Cryo-EM
Thermo Fisher Scientific
Automating the Expi293™ PRO Expression System for High Throughput Protein Expression
Thermo Fisher Scientific
De-Risking Antibody Development Early: Combining High-Yield Expression with Deep Developability Profiling
Thermo Fisher Scientific
Driving AOC and ADC success with precision bioconjugation and trafficking insights
Thermo Fisher Scientific
Expi293™ PRO Expression System: Improved Expression Across a Broad Range of Proteins, Product Quality Assessments and Purification Compatibility
Thermo Fisher Scientific
High-Throughput Media and Feed Screening
Thomson Instrument Company
21-Fold Increase in Plasmid Production Yield Compared to Traditional Methods
Thomson Instrument Company
Comparison of Thomson Optimum Growth® 7L Flasks vs Ambr® 250 Bioreactor Systems Using Stable CHO Cells
Thomson Instrument Company
Thomson 7L Flask Replacing Bioreactor and Cell Bags between 5L to 6L/Flask – Ability to Grow up to 35L/Shaker
Thomson Instrument Company
Universal Rapid Clear® 24-Well Filter Plate (7mL); A 5-Minute Spin for Clarification Solution for all Molecule Types
Tsingke Biotech
AI-Assisted Antibody Discovery: Integrating Codon Optimization, Single B Cell Screening, and Computational Humanization
Tufts University
Doxorubicin-Induced Fibroblast Activation and Pro-Invasive Changes in ECM can be Suppressed by Nintedanib
Twist Bioscience
Antibody Discovery from Immune VHH Library Using Yeast Surface Display
Twist Bioscience
Fast and Scalable 1.8kb Gene Pool Assembly Platform for High-Throughput Screening Applications
Twist Bioscience
Rapid Discovery of Hundreds of Rabbit mAbs with High Affinity and Cell Binding Against CD19 Utilizing the Beacon Optofluidic Platform
University College London
Glycopeptide Phage Display for the Discovery of New Treatments Against Pathogenic Lectins
University Medical Center Hamburg-Eppendorf
Validation and Characterization of Antibodies Against Cancer Targets in >10,000 Tumor Tissue Samples from Nearly All Human Cancer Types
University of California, San Francisco
Biparatopic and Tetravalent Siglec-10 Antibodies Modulate Immune Cell Reactivity
University of California, San Francisco
Structure-Guided Engineering of a Conformation-Specific Antibody–Drug Conjugate for AML
University of Lisbon
In Vivo Phage Display for the Discovery of Functional Tumor-Targeting and BBB-Crossing Antibodies
University of Michigan
Computational Modeling of Antibody-Drug Conjugates (ADCs) for HIV Treatment
University of Michigan
Dual-Targeted Oligoshuttles Mediate Efficient Reduction of Neuronal Gene Expression After Peripheral Administration
University of Michigan
Neurocytokine Shuttles for Efficient and Sustained CNS Immunomodulation
University of Minnesota, Twin Cities
Engineering Isoform-Specific Miniprotein Binders to the Fetal Form of the Insulin Receptor
University of Minnesota, Twin Cities
StrucNS Reveals Interaction-Weighted Network Topology as the Driving Predictor of Absolute Stability of Natural and De Novo Proteins
University of Nottingham
Protein Nanocages for Targeted Drug Delivery and Intracellular Cargo Release
University of Oxford
The Molecular Reach of Antibodies Determined by a Novel SPR-Based Assay Is Independent of Their Isotype
University of Oxford
Using CombiCells to Measure Antigen Sensitivity of T Cell Engagers
University of Pennsylvania
Autoantibody-Based Antibody-Drug Conjugates as Personalized Cancer Therapy
University of Pennsylvania
Compact Helical Bundle Scaffolds as High-Brightness NIR Probes for Fluorescence-Guided Surgery
University of Texas, Austin
Leveraging the Tumor Microenvironment for Conditional Antibody-Drug Conjugate Activation
University of Texas, Austin
Multimeric Designed Single Chain Antibody (MeDuSA): A Nanobody Fc-Based Platform for Tri-Specific Antibodies
University of Texas, Austin
Taming the Beast: A Discovery Pipeline for Multimeric Nanobody-Fc Therapeutics Targeting Pseudomonas aeruginosa
University of Utah
Functional Flexibilities and Constraints of VRC01 Lineage HIV Broadly Neutralizing Antibodies Revealed by Deep Mutational Scanning
University of Utah
Integrating Machine Learning with MDS to Improve PancACe
University of Washington
Computational Design of Bifaceted Protein Nanomaterials With Tailorable Properties
University of Washington
De Novo Design and Engineering of Sequence-Specific Proteases Using Deep Learning
University of Washington
Design, Stabilize, Design: Using a Variety of Machine Learning Tools to Create De Novo TLRs and Their Antibodies
University of Washington
Identification and Biophysical Characterization of a Novel Domain-Swapped Camelid Antibody Specific for Fentanyl
University of Washington
Mapping Polyclonal Antibody Epitopes in Native Environments Using Enrichment-Coupled HDX-MS
University of Washington
Structural Clarity for Biologics: High-Resolution Protein Characterization Services from Baselayer Biosciences
Vaccinex
Antibody Discovery for Complex Membrane Antigens
Vector Laboratories
Comparing Potential Bispecific Formats Comprising of Trastuzumab and a Humanized OKT3
Vector Laboratories
Novel Tools for Spatial Profiling of Protein Glycosylation in Cancer Biology
Vector Laboratories
Synergistic Strategies for Biologic Design and Functionalization Using Modular Chemistry and Antibody Engineering
Viva Biotech
Bi-Specific Antibody Generation - In House Study by Controlled Fab-Arm Exchange (cFAE)
Vivaproducts, Inc.
Rapid Purification of IgG Samples in Novel 96-Well Dialyzer with External Reservoir
VRG Therapeutics Ltd.
AI-MPRO: Tackling Challenging Targets with De Novo Miniproteins
Washington University in Saint Louis
Application of Glatiramoid Polypeptides in Cancer Immunotherapy
Washington University in Saint Louis
High-Throughput Mapping of Hemagglutinin pH Stability Using Yeast Display and Deep Mutational Scanning
Watchmaker Genomics
In Silico Optimisation of Inhibitor Protein with Improved Thermostability and Expression
Waters Corporation
Comprehensive LC-MS Analytical Assays for Antibody-Oligonucleotide Conjugate (AOC) and siRNA Linker-Payload Characterization
Waters Corporation
Orthogonal Approaches to Aggregation Risk Monitoring and Screening for Complex Biologics
Way Biosolutions
Enabling Active Learning-Guided Protein Engineering Through Rapid Variant DNA Assembly
Weizmann Institute
Computational Design of Synthetic Antibody Repertoires for Enhanced Developability
Wheeler Bio
Luedeking-Piret Regression for Multi-Step-Ahead Forecasting and Clone Selection in Monoclonal Antibodies Biomanufacturing
Wonkwang University
Broad-Reactive Monoclonal Antibodies Targeting Influenza H5Nx for Integrated Pandemic Readiness
WuXi Biologics
In-Depth SPR Characterization Throughout Biologics Drug Discovery and Development
WuXi Biologics
Translational In Vivo Characterization Platform for T Cell Engagers via NHP and hFcRn Mice
WuXi XDC
Accelerating Bioconjugates Discovery via Optimized Linker-Payload Customization Platform at WuXi XDC
WuXi XDC
Driving Dual-Payload ADC (dp-ADC) Development with Proprietary WuXiDARx™, X-LinC, and WuXiTecan-2
WuXi XDC
Integrated Bioconjugate Discovery Services at WuXi XDC
XL-protein GmbH
PASylation® in Enzyme Engineering: Impact on Biophysical Properties, in Vivo Half-Life and Catalytic Activity
XTOP Biotherapeutic, Inc.
CrossBody: A Variable Region Domain-Splitting Multispecific Antibody Architecture Enabling Tumor-Selective Target Engagement for Precision Immunotherapy
Yonsei University
Fluorosulfuryl Derivatives of Established Drugs for Imaging Radiopharmaceuticals
YUMAB GmbH
Next-Generation TCR-Like Antibodies with Improved Specificity Profiles
Yurogen Biosystems LLC
Development and Characterization of a Rabbit Monoclonal Antibody for Specific Detection of Human IgG-Fc (YTE Mutation) Antibody
Yurogen Biosystems LLC
Development of a Humanized Anti-CDH3 Antibody Using a Single-Cell Strategy for Diseases with Aberrant CDH3 Expression
Yurogen Biosystems LLC
Single B Cell Platform Enables TCR-Mimic Rabbit Antibodies Against EGFR Neoantigen
Zymeworks
Uniting Discovery Strategy and Engineering for the Best-in-Class Antibodies for ADC